AccessibilityHelp

Frazier Life Sciences Acquisition Corp II(NASDAQ) FLSC

Market Cap$99.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)+0%
5 YearN/A
1 YearN/A
1 MonthN/A
$10.30
+0.29%
+0.03Today
Frazier Life Sciences Acquisition Corp II last closing stock price
MetricPriceDate
Last closeUSD 10.302026-10-23
Frazier Life Sciences Acquisition Corp II stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.48%USD 10.352026-10-16
Since inception+0.1%USD 10.292026-10-14

Frazier Life Sciences Acquisition Corp II Financials at a Glance

Market Cap

$99.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$0.01

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

4.99 (High)

Price

$10.30

Volume

20,001

Open

$10.30

Previous Close

$10.30

Daily Range

$10.27 - $10.32

52-Week Range

$10.00 - $10.63

Estimated Earnings Date

N/A

FLSC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Frazier Life Sciences Acquisition Corp II

Frazier Life Sciences Acquisition Corp. II is a blank-check company focused on identifying and merging with innovative life sciences businesses. The company aims to leverage its expertise to create value through strategic acquisitions in the healthcare sector.

Products and Services
  • Specializes in mergers and acquisitions within the life sciences industry
  • Targets innovative companies with growth potential
  • Provides capital and strategic support to portfolio companies
Growth Outlook
  • Life sciences sector projected to grow significantly in the coming years
  • Increased demand for healthcare solutions drives acquisition opportunities
  • Strategic partnerships expected to enhance market positioning
Financial Highlights
  • Market capitalization stands at approximately $78.45 million
  • Stock price range over the past year is $10.18 to $10.59
  • Average trading volume indicates steady investor interest
Frazier Life Sciences Acquisition Corp. II operates in the dynamic life sciences sector, which is experiencing robust growth driven by innovation and demand for healthcare solutions. The company’s focus on strategic acquisitions positions it well to capitalize on emerging opportunities. With a solid market capitalization and consistent trading activity, Frazier Life Sciences Acquisition Corp. II presents a compelling option for investors interested in the life sciences landscape.
AI Generated • Oct 16, 2026

Industry

Capital Markets

Sector

Financials

Employees

4

CEO

Albert Cha, MD, PhD

Headquarters

Palo Alto, CA 94304, US

FLSC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$99.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

9.68M

Volume

20.00K

Avg. Volume

184.57K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Frazier Life Sciences Acquisition Corp II Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

N/A

N/A

Market Cap

$99.65MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

4

N/A

Net Income

-$0.01

N/A

EBITDA

-$0.01

N/A

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$0.01

N/A

Total Debt

$0.01

N/A

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.01

N/A

Short Term Debt

$0.00

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,635.64-0.00%
^DJIDJI
$52,319.47-0.01%
^IXICNASDAQ
$26,002.43-0.00%
BTCBitcoin
$81,534.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About FLSC

What is the current price of Frazier Life Sciences Acquisition Corp II?

Frazier Life Sciences Acquisition Corp II is trading at $10.30 per share.

What is the 52-week range for Frazier Life Sciences Acquisition Corp II?

Over the past 52 weeks, Frazier Life Sciences Acquisition Corp II has traded between $10.00 and $10.63.

How much debt does Frazier Life Sciences Acquisition Corp II have?

As of the most recent reporting period, Frazier Life Sciences Acquisition Corp II reported total debt of $10.50K.

How much cash does Frazier Life Sciences Acquisition Corp II have on hand?

Frazier Life Sciences Acquisition Corp II reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Frazier Life Sciences Acquisition Corp II’s dividend yield?

Frazier Life Sciences Acquisition Corp II does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services